DAFNA Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
471,000
+331,000
| +236% | +$821K | 0.32% | 54 |
|
|
2025
Q1 | $217K | Hold |
140,000
| – | – | 0.06% | 81 |
|
|
2024
Q4 | $300K | Buy |
140,000
+15,000
| +12% | +$32.1K | 0.08% | 77 |
|
|
2024
Q3 | $544K | Buy |
+125,000
| New | +$544K | 0.13% | 70 |
|
|
2023
Q1 | – | Sell |
-97,500
| Closed | -$176K | – | 74 |
|
|
2022
Q4 | $176K | Sell |
97,500
-216,100
| -69% | -$389K | 0.05% | 75 |
|
|
2022
Q3 | $530K | Hold |
313,600
| – | – | 0.14% | 68 |
|
|
2022
Q2 | $771K | Hold |
313,600
| – | – | 0.21% | 69 |
|
|
2022
Q1 | $869K | Buy |
313,600
+107,500
| +52% | +$298K | 0.23% | 73 |
|
|
2021
Q4 | $1.1M | Buy |
+206,100
| New | +$1.1M | 0.28% | 63 |
|